Dermatology
From the Journals
Biologics show signs of delaying arthritis in psoriasis patients
Treatment with the interleukin-12/23 inhibitor ustekinumab or interleukin-23 inhibitors (guselkumab, risankizumab, tildrakizumab) was linked to a...
Latest News
FDA to review dupilumab for treating chronic spontaneous urticaria
Dupilumab enters the approval process for adolescents and adults with uncontrolled CSU.
Latest News
FDA accepts application for topical molluscum treatment
A new drug application for berdazimer gel 10.3% for the treatment of molluscum will be reviewed by the FDA.
Latest News
Pembrolizumab before and after melanoma surgery boosts outcomes
"It's not just what you give; it's when you give it," said lead author Sapna Patel, MD, in a press release.
From the Journals
Nicotinamide does not prevent skin cancer after organ transplant
Nicotinamide (vitamin B3) has been shown to prevent nonmelanoma skin cancers in healthy, immunocompetent people, so physicians routinely prescribe...
Latest News
Skin reactions from melanoma targeted and immune therapies range from pruritus to SJS
Appearance of vitiligo is regarded as a good prognostic factor in the treatment of melanoma with various checkpoint inhibitors alone or in...
Latest News
Expert dispels myths about hair care in patients with skin of color
“You want to perform the scalp and hair exam with cultural humility,” Dr. Candrice R. Health said.
From the Journals
Isolated nail psoriasis may bring arthritis into play
The review of 20 years of cases show delayed diagnosis, delineate clinical features, and suggest a relationship with PsA.
Latest News
Topical or intralesional cidofovir an option for recalcitrant warts
Some studies have suggested that one in three children in primary school suffers from warts.
Latest News
Treating nail psoriasis: Intralesional injections and biologics
When Dr. Armstrong performs intramatricial injections, she uses triamcinolone acetonide at 10 mg/mL.
Feature
What’s holding back physicians from prescribing biosimilars? Four specialties weigh in
Physicians surveyed from four different specialties reported that they were generally comfortable prescribing biosimilars, but greater discounts...